IDNA vs. HEAL
IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) and HEAL (Global X HealthTech ETF) are both Health & Biotech Equities funds - IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index while HEAL tracks the Global X HealthTech Index. Both are passively managed. Over the past 5 years, IDNA returned -8.26%/yr vs -14.38%/yr for HEAL. A 0.71 correlation means they provide meaningful diversification when combined. IDNA charges 0.47%/yr vs 0.50%/yr for HEAL.
Performance
IDNA vs. HEAL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDNA achieves a 9.51% return, which is significantly higher than HEAL's -14.58% return.
IDNA
- 1D
- -2.18%
- 1M
- -2.18%
- YTD
- 9.51%
- 6M
- 10.53%
- 1Y
- 41.74%
- 3Y*
- 6.48%
- 5Y*
- -8.26%
- 10Y*
- —
HEAL
- 1D
- -2.31%
- 1M
- -1.49%
- YTD
- -14.58%
- 6M
- -19.25%
- 1Y
- -20.75%
- 3Y*
- -10.11%
- 5Y*
- -14.38%
- 10Y*
- —
IDNA vs. HEAL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 9.51% | 17.26% | -0.72% | -7.63% | -42.28% | -3.98% | 20.41% |
HEAL Global X HealthTech ETF | -14.58% | -0.62% | -2.87% | -12.61% | -29.99% | -14.21% | 23.87% |
Correlation
The correlation between IDNA and HEAL is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.58 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.62 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.70 |
Correlation (All Time) Calculated using the full available price history since Jul 31, 2020 | 0.71 |
The correlation between IDNA and HEAL shifts across timeframes, from 0.58 (1 year) to 0.71 (all time), reflecting how their relationship changes across market environments.
IDNA vs. HEAL - Sectors Allocation Comparison
Sectors
IDNA
HEAL
Healthcare
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Real Estate
-
-
Technology
-
Utilities
-
-
Healthcare
IDNA
HEAL
Industrials
IDNA
HEAL
-
Basic Materials
IDNA
-
HEAL
-
Communication Services
IDNA
-
HEAL
-
Consumer Cyclical
IDNA
-
HEAL
-
Consumer Defensive
IDNA
-
HEAL
-
Energy
IDNA
-
HEAL
-
Financial Services
IDNA
-
HEAL
-
Real Estate
IDNA
-
HEAL
-
Technology
IDNA
-
HEAL
Utilities
IDNA
-
HEAL
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDNA vs. HEAL — Risk / Return Rank
IDNA
HEAL
IDNA vs. HEAL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and Global X HealthTech ETF (HEAL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IDNA | HEAL | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.71 | -0.95 | +2.67 |
Sortino ratioReturn per unit of downside risk | 2.48 | -1.30 | +3.78 |
Omega ratioGain probability vs. loss probability | 1.28 | 0.86 | +0.42 |
Calmar ratioReturn relative to maximum drawdown | 4.09 | -0.66 | +4.75 |
Martin ratioReturn relative to average drawdown | 11.79 | -1.34 | +13.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IDNA | HEAL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.71 | -0.95 | +2.67 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.29 | -0.55 | +0.26 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.10 | -0.39 | +0.49 |
Drawdowns
IDNA vs. HEAL - Drawdown Comparison
The maximum IDNA drawdown since its inception was -68.26%, roughly equal to the maximum HEAL drawdown of -65.76%. Use the drawdown chart below to compare losses from any high point for IDNA and HEAL.
Loading charts...
Drawdown Indicators
| IDNA | HEAL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.26% | -65.76% | -2.50% |
Max Drawdown (1Y)Largest decline over 1 year | -10.66% | -30.71% | +20.05% |
Max Drawdown (3Y)Largest decline over 3 years | -29.73% | -35.78% | +6.05% |
Max Drawdown (5Y)Largest decline over 5 years | -68.26% | -60.36% | -7.90% |
Current DrawdownCurrent decline from peak | -46.01% | -63.12% | +17.11% |
Average DrawdownAverage peak-to-trough decline | -36.24% | -43.01% | +6.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.70% | 15.04% | -11.34% |
Volatility
IDNA vs. HEAL - Volatility Comparison
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a higher volatility of 7.24% compared to Global X HealthTech ETF (HEAL) at 5.09%. This indicates that IDNA's price experiences larger fluctuations and is considered to be riskier than HEAL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDNA | HEAL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.24% | 5.09% | +2.15% |
Volatility (6M)Calculated over the trailing 6-month period | 18.21% | 15.71% | +2.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.51% | 21.87% | +2.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.42% | 26.36% | +2.06% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.53% | 26.19% | +3.34% |
IDNA vs. HEAL - Expense Ratio Comparison
IDNA has a 0.47% expense ratio, which is lower than HEAL's 0.50% expense ratio.
Dividends
IDNA vs. HEAL - Dividend Comparison
IDNA's dividend yield for the trailing twelve months is around 1.08%, more than HEAL's 0.39% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
HEAL Global X HealthTech ETF | 0.39% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.08% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Frequently Asked Questions
IDNA and HEAL have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (7.24%) compared to HEAL (5.09%). In terms of maximum drawdown, IDNA dropped -68.26% vs HEAL's -65.76%.
On 5-year performance, IDNA leads with -8.26% vs -14.38% for HEAL. On fees, IDNA is cheaper at 0.47% per year. On volatility, HEAL has been the lower-risk option at 5.09%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IDNA has performed better with a -8.26% return vs -14.38%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IDNA is cheaper with a 0.47% expense ratio, compared with 0.50% for HEAL.
IDNA has the higher dividend yield at 1.08%, compared with 0.39% for HEAL.
IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while HEAL tracks Global X HealthTech Index. They also come from different issuers: iShares and Global X. Their fees differ too: 0.47% for IDNA and 0.50% for HEAL.
IDNA currently has the higher Sharpe Ratio (1.71 vs -0.95), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDNA and HEAL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer